Read More Pharma Industry News CenterLab’s anti-diabetic drug candidate CS02 meets primary endpoint in phase 2 trial Taiwanese pharma company Center Laboratories (CenterLab) said that its anti-diabetic drug candidate CS02 has met the primary endpoint… bypharmanewsdailyJuly 11, 2020